rs2207782

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001010848.4(NRG3):​c.823+121280G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 152,088 control chromosomes in the GnomAD database, including 20,158 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 20158 hom., cov: 32)

Consequence

NRG3
NM_001010848.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.742

Publications

14 publications found
Variant links:
Genes affected
NRG3 (HGNC:7999): (neuregulin 3) This gene is a member of the neuregulin gene family. This gene family encodes ligands for the transmembrane tyrosine kinase receptors ERBB3 and ERBB4 - members of the epidermal growth factor receptor family. Ligand binding activates intracellular signaling cascades and the induction of cellular responses including proliferation, migration, differentiation, and survival or apoptosis. This gene encodes neuregulin 3 (NRG3). NRG3 has been shown to activate the tyrosine phosphorylation of its cognate receptor, ERBB4, and is thought to influence neuroblast proliferation, migration and differentiation by signalling through ERBB4. NRG3 also promotes mammary differentiation during embryogenesis. Linkage studies have implicated this gene as a susceptibility locus for schizophrenia and schizoaffective disorder. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but their biological validity has not been verified.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.776 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001010848.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRG3
NM_001010848.4
MANE Select
c.823+121280G>A
intron
N/ANP_001010848.2P56975-4
NRG3
NM_001370084.1
c.823+121280G>A
intron
N/ANP_001357013.1D9ZHP6
NRG3
NM_001370081.1
c.823+121280G>A
intron
N/ANP_001357010.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRG3
ENST00000372141.7
TSL:1 MANE Select
c.823+121280G>A
intron
N/AENSP00000361214.2P56975-4
NRG3
ENST00000404547.5
TSL:1
c.823+121280G>A
intron
N/AENSP00000384796.1P56975-1
NRG3
ENST00000556918.5
TSL:1
c.135+119348G>A
intron
N/AENSP00000451376.1D9ZHQ7

Frequencies

GnomAD3 genomes
AF:
0.458
AC:
69558
AN:
151970
Hom.:
20102
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.783
Gnomad AMI
AF:
0.299
Gnomad AMR
AF:
0.512
Gnomad ASJ
AF:
0.332
Gnomad EAS
AF:
0.767
Gnomad SAS
AF:
0.436
Gnomad FIN
AF:
0.336
Gnomad MID
AF:
0.347
Gnomad NFE
AF:
0.255
Gnomad OTH
AF:
0.425
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.458
AC:
69672
AN:
152088
Hom.:
20158
Cov.:
32
AF XY:
0.464
AC XY:
34466
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.783
AC:
32508
AN:
41520
American (AMR)
AF:
0.513
AC:
7838
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
1151
AN:
3468
East Asian (EAS)
AF:
0.767
AC:
3956
AN:
5158
South Asian (SAS)
AF:
0.435
AC:
2102
AN:
4830
European-Finnish (FIN)
AF:
0.336
AC:
3549
AN:
10558
Middle Eastern (MID)
AF:
0.339
AC:
99
AN:
292
European-Non Finnish (NFE)
AF:
0.255
AC:
17304
AN:
67962
Other (OTH)
AF:
0.423
AC:
892
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1526
3053
4579
6106
7632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.405
Hom.:
15939
Bravo
AF:
0.491
Asia WGS
AF:
0.600
AC:
2087
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.46
DANN
Benign
0.62
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2207782; hg19: chr10-83757199; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.